Clinical trial
MELISA Trial: Mapping sEntinel Lymph Node in Initial StAges of Ovarian Cancer
NCT05184140 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MELISA Trial: Mapping sEntinel Lymph Node in Initial StAges of Ovarian Cancer
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- May 1, 2023
- Enrollment
- 62 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer, sentinel lymph node